Legend Biotech Corp (LEGN)
45.44
+0.03
(+0.07%)
USD |
NASDAQ |
May 06, 10:32
Legend Biotech Stock Buybacks (Quarterly): 0.00 for Dec. 31, 2023
Stock Buybacks (Quarterly) Chart
Historical Stock Buybacks (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 0.00 |
| September 30, 2023 | 0.00 |
| June 30, 2023 | -583.69M |
| March 31, 2023 | |
| December 31, 2022 | 0.00 |
| September 30, 2022 | -377.64M |
| June 30, 2022 | 0.00 |
| Date | Value |
|---|---|
| March 31, 2022 | |
| December 31, 2021 | -323.44M |
| September 30, 2021 | 0.00 |
| June 30, 2021 | -300.00M |
| March 31, 2021 | |
| December 31, 2020 | 0.00 |
| September 30, 2020 | -462.08M |
Stock Buyback Definition
Stock buybacks are when companies buy back their own stock, removing it from the marketplace. Stock buybacks increase the value of the remaining shares because there is now less common stock outstanding and company earnings are split among fewer shares.
Stock Buybacks (Quarterly) Range, Past 5 Years
-583.69M
Minimum
Jun 2023
--
Maximum
Dec 2020
-186.08M
Average
--
Median
Dec 2020
Stock Buybacks (Quarterly) Benchmarks
| Johnson & Johnson | 1.475B |
| Bristol-Myers Squibb Co | 0.00 |
| 2seventy bio Inc | 0.00 |
| Exelixis Inc | 185.38M |
| Alnylam Pharmaceuticals Inc | -- |